Evidence map›Paper›PMID 30237788›Full record

ReviewFrontiers in microbiology2018

A Comprehensive Review on Equine Influenza Virus: Etiology, Epidemiology, Pathobiology, Advances in Developing Diagnostics, Vaccines, and Control Strategies.

Raj K Singh, Kuldeep Dhama, Kumaragurubaran Karthik, Rekha Khandia, Ashok Munjal, Sandip K Khurana, Sandip Chakraborty, Yashpal S Malik, Nitin Virmani, Rajendra Singh and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Raj K SinghICAR-Indian Veterinary Research Institute, Bareilly, India.
Kuldeep DhamaDivision of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, India.
Kumaragurubaran KarthikCentral University Laboratory, Tamil Nadu Veterinary and Animal Sciences University, Chennai, India.
Rekha KhandiaDepartment of Biochemistry and Genetics, Barkatullah University, Bhopal, India.
Ashok MunjalDepartment of Biochemistry and Genetics, Barkatullah University, Bhopal, India.
Sandip K KhuranaNational Research Centre on Equines, Hisar, India.
Sandip ChakrabortyDepartment of Veterinary Microbiology, College of Veterinary Sciences and Animal Husbandry, West Tripura, India.
Yashpal S MalikDivision of Biological Standardization, ICAR-Indian Veterinary Research Institute, Bareilly, India.
Nitin VirmaniNational Research Centre on Equines, Hisar, India.
Rajendra SinghDivision of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, India.
Bhupendra N TripathiNational Research Centre on Equines, Hisar, India.
Muhammad MunirDivision of Biomedical and Life Sciences, Lancaster University, Lancaster, United Kingdom.
Johannes H van der KolkDivision of Clinical Veterinary Medicine, Swiss Institute for Equine Medicine (ISME), Vetsuisse Faculty, University of Bern and Agroscope, Bern, Switzerland.
Indian Veterinary Research Institute · INNational Research Centre on Equines · INBarkatullah University · INLancaster University · GBTamil Nadu Veterinary and Animal Sciences University · INUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among all the emerging and re-emerging animal diseases, influenza group is the prototype member associated with severe respiratory infections in wide host species. Wherein, Equine influenza (EI) is the main cause of respiratory illness in equines across globe and is caused by equine influenza A virus (EIV-A) which has impacted the equine industry internationally due to high morbidity and marginal morality. The virus transmits easily by direct contact and inhalation making its spread global and leaving only limited areas untouched. Hitherto reports confirm that this virus crosses the species barriers and found to affect canines and few other animal species (cat and camel). EIV is continuously evolving with changes at the amino acid level wreaking the control program a tedious task. Until now, no natural EI origin infections have been reported explicitly in humans. Recent advances in the diagnostics have led to efficient surveillance and rapid detection of EIV infections at the onset of outbreaks. Incessant surveillance programs will aid in opting a better control strategy for this virus by updating the circulating vaccine strains. Recurrent vaccination failures against this virus due to antigenic drift and shift have been disappointing, however better understanding of the virus pathogenesis would make it easier to design effective vaccines predominantly targeting the conserved epitopes (HA glycoprotein). Additionally, the cold adapted and canarypox vectored vaccines are proving effective in ceasing the severity of disease. Furthermore, better understanding of its genetics and molecular biology will help in estimating the rate of evolution and occurrence of pandemics in future. Here, we highlight the advances occurred in understanding the etiology, epidemiology and pathobiology of EIV and a special focus is on designing and developing effective diagnostics, vaccines and control strategies for mitigating the emerging menace by EIV.

Indexed as

controldiagnosisepidemiologyequineinfluenza viruspathogenesispreventionvaccine

Identifiers

PMID30237788
PMCPMC6135912
OpenAlexW2892233203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.